Ontrak, Inc. (NASDAQ:OTRK - Get Free Report) saw a large growth in short interest in September. As of September 30th, there was short interest totalling 61,000 shares, a growth of 315.0% from the September 15th total of 14,700 shares. Based on an average daily trading volume, of 1,620,000 shares, the short-interest ratio is currently 0.0 days. Currently, 4.9% of the shares of the stock are short sold.
Ontrak Price Performance
Shares of Ontrak stock traded down $0.09 during trading on Thursday, reaching $2.26. 476,996 shares of the company's stock were exchanged, compared to its average volume of 698,521. Ontrak has a 1-year low of $1.81 and a 1-year high of $21.29. The firm's 50-day moving average price is $0.80 and its 200 day moving average price is $0.46. The company has a debt-to-equity ratio of 0.43, a quick ratio of 3.64 and a current ratio of 3.64. The company has a market cap of $108.41 million, a P/E ratio of -0.55 and a beta of 2.56.
Ontrak (NASDAQ:OTRK - Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.09). Ontrak had a negative return on equity of 238.43% and a negative net margin of 222.54%. The firm had revenue of $2.45 million during the quarter, compared to analyst estimates of $2.60 million. During the same period in the previous year, the company earned ($1.84) EPS. As a group, research analysts anticipate that Ontrak will post -7.35 earnings per share for the current year.
Analyst Ratings Changes
Separately, Roth Mkm lowered their price target on Ontrak from $4.00 to $3.00 and set a "buy" rating for the company in a report on Friday, August 9th.
Check Out Our Latest Stock Report on OTRK
Ontrak Company Profile
(
Get Free Report)
Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ontrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ontrak wasn't on the list.
While Ontrak currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.